Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Non-Current Assets (2021 - 2025)

Medicinova (MNOV) has disclosed Non-Current Assets for 7 consecutive years, with $14.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets changed N/A to $14.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $58.7 million, a N/A change, with the full-year FY2025 number at $14.6 million, changed N/A from a year prior.
  • Non-Current Assets was $14.6 million for Q4 2025 at Medicinova, roughly flat from $14.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $25.2 million in Q3 2022 to a low of $14.6 million in Q4 2025.
  • A 5-year average of $15.6 million and a median of $15.1 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: skyrocketed 63.24% in 2022, then plummeted 40.02% in 2023.
  • Medicinova's Non-Current Assets stood at $15.4 million in 2021, then surged by 63.94% to $25.2 million in 2022, then tumbled by 40.2% to $15.1 million in 2023, then fell by 1.6% to $14.9 million in 2024, then fell by 1.63% to $14.6 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Non-Current Assets are $14.6 million (Q4 2025), $14.7 million (Q3 2025), and $14.7 million (Q2 2025).